final 1 Flashcards

1
Q

It uses computer simulations to predict the behavior of molecules and their interactions.

A

Molecular modeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

It virtually tests millions of compounds against target molecules, identifying potential drug candidates for further research and development.

A

In silico screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

It automates the testing of large libraries of compounds against a specific target.

A

High Throughput Screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

It enables researchers to rapidly screen thousands or millions of compounds, identifying potential drug candidates.

A

High Throughput Screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HTS helps identify “___,” compounds that show promising activity against the target, paving the way for further investigation.

A

hits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

It systematically generates and screens
large libraries of chemical compounds.

It involves systematically combining different building blocks to create diverse molecules.

A

Combinatorial chemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

These libraries are then screened against biological targets to identify potential drug candidates, enabling the exploration of a vast chemical space.

A

Compound Libraries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

It provides crucial insights into the three-
dimensional structures of proteins, their interactions with other molecules, and their functional roles in biological processes.

A

Structural biology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

These strategies focus on designing drugs that bind to specific protein sites, modulating their activity and potentially inhibiting disease progression.

A

Protein targeting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

These are used to understand how fragments bind.

A

X-ray crystallography and NMR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Leads with improved properties are further optimized to become drug
candidates.

A

Fragment-Based Drug Discovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In Fragment-Based Drug Discovery, Fragments are modified and combined to improve:

A

binding affinity and potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Starts with small molecules, “fragments”, that bind to a target protein.

A

Fragment-Based Drug Discovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

It allows simultaneous analysis of multiple cellular parameters in a single experiment, providing a comprehensive
view of drug effects.

A

High-Content Screening (HCS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

This approach enhances data quality and accelerates the identification of promising drug candidates.

A

High-Content Screening (HCS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

They mimic the complex environment of living tissues, providing a more accurate
representation of drug responses.

A

Three-dimensional cell culture models

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

These models improve prediction of drug efficacy and reduce the need for animal testing.

A

Three-dimensional cell culture models

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

It studies the entire genome, including genes, mutations, and variations. This provides insights into genetic predispositions to diseases and potential drug targets.

A

Genomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

It focuses on proteins, analyzing their structure, function, and interactions. It helps identify biomarkers and understand how drugs affect protein pathways.

A

Proteomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Combining __ and ___ offers a more comprehensive understanding of disease mechanisms. It enables the development of personalized therapies based on individual genetic profiles and protein expression patterns.

A

genomics

proteomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

AI can analyze vast datasets to identify potential drug targets, speeding up the discovery process.

A

Target Identification (Artificial Intelligence and Machine Learning)

22
Q

These can rapidly screen millions of molecules to identify promising drug candidates.

A

AI algorithms

23
Q

They can predict drug efficacy, safety, and pharmacokinetic properties, reducing the risk of failure in later stages.

A

AI models

24
Q

AI can optimize ___, making them more
efficient and cost-effective

A

clinical trial designs

25
Q

It is a crucial aspect of drug discovery.

A

ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) modeling

26
Q

They utilize computational approaches to estimate a drug candidate’s pharmacokinetic and pharmacodynamic properties.

A

Predictive ADMET models

27
Q

How well a drug is absorbed into the
bloodstream

A

Absorption

28
Q

How a drug spreads throughout the body.

A

Distribution

29
Q

How a drug is broken down in the body.

A

Metabolism

30
Q

How a drug is removed from the body.

A

Excretion

31
Q

The potential harmful effects of a drug.

A

Toxicity

32
Q

These are tiny chips that mimic the human body’s organ functions.

A

Microfluidic devices

33
Q

These platforms enable researchers to study drug effects and responses in a controlled environment.

A

Microfluidic Devices

34
Q

These are a powerful tool for drug discovery and development.

They provide a more physiologically relevant model than traditional cell cultures.

A

Organ-on-a-chip systems

35
Q

These models improve predictions of drug efficacy and toxicity in human trials.

A

Organ-on-a-chip systems

36
Q

It utilizes genetic, genomic, and other data to create customized treatment plans.

This approach considers individual
differences in genes, lifestyle, and
environment, allowing for more targeted
and effective therapies.

A

Personalized medicine

37
Q

These tests help identify patients most
likely to benefit from a specific treatment, predicting drug response and
potential adverse effects.

A

Companion Diagnostics

38
Q

This emerging field focuses on developing targeted therapies and diagnostics for specific patient populations, improving treatment outcomes and reducing unnecessary side effects.

A

Precision Medicine

39
Q

These are biological indicators that
can help predict disease risk, monitor
disease progression, or evaluate the
effectiveness of treatments.

A

Biomarkers

40
Q

In clinical trials, it allows for personalized medicine approaches, tailoring treatments to individual patients based on their unique biological characteristics.

A

Biomarker validation

41
Q

These can be used to develop accurate and sensitive diagnostic tests that enable early detection and intervention, improving patient outcomes.

A

Biomarkers

42
Q

Allow for modifications to trial protocols based on accumulating data.

A

Adaptive Designs

43
Q

Enrolls patients with different tumor types but similar genetic alterations.

A

Basket Trials

44
Q

Test multiple drugs simultaneously against a single target.

A

Umbrella Trials

45
Q

Evaluate various therapies for a specific disease or condition.

A

Platform Trials

46
Q

Ethical Considerations and Patient

A

• Centricity
• Informed Consent
• Data Privacy
• Equity and Access
• Transparency and Communication

47
Q

These are often stigmatized and
undertreated, requiring innovative therapies and support systems.

A

Mental health disorders

48
Q

It is a growing concern, leading to
a need for novel antibiotics and antiviral therapies.

A

Antimicrobial resistance

49
Q

Many rare diseases lack effective treatments. Drug development for these
diseases is often challenging due to limited patient populations and high costs.

A
50
Q

Prevalent in developing countries,
it often lack adequate resources for research and development of new
treatments.

A

Tropical diseases